Johnson & Johnson (NEO:JNJ)

Market Cap	573.36B
Revenue (ttm)	128.02B
Net Income (ttm)	20.27B
Shares Out	n/a
EPS (ttm)	8.35
PE Ratio	28.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,369
Average Volume	15,293
Open	21.80
Previous Close	21.69
Day's Range	21.54 - 21.84
52-Week Range	18.75 - 22.50
Beta	0.52
RSI	70.53
Earnings Date	Apr 15, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Cboe Canada
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD